William E. Matchett

Institute of Immunology — Croatia

Medicine · Health Sciences

14h-index796citations24works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(10), Virus-based gene therapy research(8), COVID-19 Clinical Research Studies(5), Viral gastroenteritis research and epidemiology(4), Respiratory viral infections research(3)

Publications24 total

Boosting corrects a memory B cell defect in SARS-CoV-2 mRNA–vaccinated patients with inflammatory bowel disease
JCI Insight·2022· 5 citedOpen Access
Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography
Nature Communications·2021· 35 citedOpen Access
Mice with diverse microbial exposure histories as a model for preclinical vaccine testing
Cell Host & Microbe·2021· 73 citedOpen Access
Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity
The Journal of Immunology·2021· 165 citedOpen Access
Nucleocapsid vaccine elicits spike-independent SARS-CoV-2 protective immunity
2021· 16 citedOpen Access
Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium
PLoS Pathogens·2021· 131 citedOpen Access
Immune Profiling to Determine Early Disease Trajectories Associated With Coronavirus Disease 2019 Mortality Rate: A Substudy from the ACTT-1 Trial
The Journal of Infectious Diseases·2021· 3 citedOpen Access
Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses
The Journal of Immunology·2021· 45 citedOpen Access
Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium
2020· 10 citedOpen Access
<scp>SARS‐CoV‐2</scp> neutralization and serology testing of <scp>COVID‐19</scp> convalescent plasma from donors with nonsevere disease
Transfusion·2020· 26 citedOpen Access
A Replicating Single-Cycle Adenovirus Vaccine Effective against Clostridium difficile
Vaccines·2020· 10 citedOpen Access
SARS-CoV-2 neutralization and serology testing of COVID-19 convalescent plasma from donors with non-severe disease
2020· 7 citedOpen Access
Single-Cycle Adenoviruses (SC-Ads) as Platforms for Immunostimulation
The Journal of Immunology·2020· 1 cited
Genetic Adjuvants in Replicating Single-Cycle Adenovirus Vectors Amplify Systemic and Mucosal Immune Responses against HIV-1 Envelope
Vaccines·2020· 16 citedOpen Access
Divergent HIV-1-Directed Immune Responses Generated by Systemic and Mucosal Immunization with Replicating Single-Cycle Adenoviruses in Rhesus Macaques
Journal of Virology·2019· 14 citedOpen Access
Providing Pedagogy Education for Aspiring Instructors at Institutions Without Formal Pedagogy Curriculum or Undergraduate Populations
Journal of College Science Teaching·2018· 1 cited
A Replicating Single-Cycle Adenovirus Vaccine Against Ebola Virus
The Journal of Infectious Diseases·2018· 19 citedOpen Access
Twin Talk Series: A novel method to foster peer‐to‐peer pedagogical training
The FASEB Journal·2018
Comparison of systemic and mucosal immunization with replicating Single cycle Adenoviruses
Global Vaccines and Immunology·2018· 10 citedOpen Access
Retargeted and detargeted adenovirus for gene delivery to the muscle
Virology·2017· 21 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Ryan A. Langlois(11), Tyler D. Bold(10), Joshua M. Thiede(9), Michael A. Barry(8), Vineet D. Menachery(7), Marc K. Jenkins(6), Stephanie S. Anguiano-Zarate(6), J. Michael Stolley(4), Sathi Wijeyesinghe(4), Vaiva Vezys(4), David Masopust(4), Jessica K. Fiege(4), Vineet Joag(3), Frances K. Shepherd(3), Clare F. Quarnstrom(3), Clayton K. Mickelson(3), Andrew G. Soerens(3), Eyob Weyu(3), Stephen D. O’Flanagan(3), Hezkiel A. Nanda(3)